Aardvark Therapeutics, Inc. Common Stock (AARD)
NASDAQ·Healthcare·Biotechnology
$5.44
-1.45%
Mkt Cap $120.42M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 23, 2026 | — | — | — | -$0.83 | -$0.81 | +2.09% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.80 | -$0.75 | +6.08% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.60 | -$0.66 | -10.00% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.67 | -$0.71 | -5.45% | — | — |
| Q1 2025 Feb 26, 2025 | — | — | — | -$0.41 | -$0.68 | -65.87% | — | — |
| Q3 2024 Sep 30, 2024 | — | — | — | — | -$0.32 | — | — | — |
| Q2 2024 Jun 30, 2024 | — | — | — | — | -$2.13 | — | — | — |
| Q1 2024 Mar 31, 2024 | — | — | — | — | -$0.17 | — | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.21 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.22 | — | — | — |